10.08 USD
-0.42 (-4%)
10.08 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 84% to TRDA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.83. This target is 66.96% above the current price.
TRDA was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about TRDA.
In the previous month the buy percentage consensus was at a similar level.
TRDA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-05 | Roth MKM | Initiate | Buy |
| 2024-11-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-26 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-05 | Oppenheimer | Initiate | Outperform |
| 2023-11-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-03 | HC Wainwright & Co. | Initiate | Buy |
| 2022-11-08 | Goldman Sachs | Maintains | Neutral |
| 2022-08-16 | Goldman Sachs | Maintains | Neutral |
| 2022-05-24 | Goldman Sachs | Maintains | Neutral |
| 2021-11-24 | Evercore ISI Group | Initiate | Outperform |
| 2021-11-23 | Cowen & Co. | Initiate | Outperform |
| 2021-11-23 | Goldman Sachs | Initiate | Neutral |
ENTRADA THERAPEUTICS INC / TRDA FAQ
What do analysts expect the price target to be for ENTRADA THERAPEUTICS INC (TRDA)?
11 analysts have analysed TRDA and the average price target is 16.83 USD. This implies a price increase of 66.96% is expected in the next year compared to the current price of 10.08.
What is the consensus rating for TRDA stock?
The consensus rating for ENTRADA THERAPEUTICS INC (TRDA) is 83.6364 / 100 . This indicates that analysts generally have a positive outlook on the stock.